rs911263 — RAD51B RAD51B RA Proxy Variant

RAD51B — A DNA Repair Gene at the Crossroads of Immune Tolerance

The RAD51B gene¹¹ RAD51B gene
RAD51 paralog B — one of five human RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, XRCC3) that assemble into the BCDX2 and CX3 complexes to coordinate double-strand DNA break repair encodes a key component of the homologous recombination (HR) machinery. Located at chromosome 14q24.1, RAD51B is most highly expressed in the testis, thymus, ovary, and spleen — tissues that undergo intensive DNA recombination. The variant rs911263 is an intronic proxy SNP that marks a haplotype at this locus associated with seropositive rheumatoid arthritis (RA) susceptibility.

The Mechanism

RAD51B forms a stable heterodimer with RAD51C as the core of the BCDX2 complex²² BCDX2 complex
RAD51B–RAD51C–RAD51D–XRCC2 — a multi-subunit complex that loads RAD51 onto damaged DNA and stabilises the presynaptic filament for homology search and strand invasion. During B-cell development, V(D)J recombination and class switch recombination generate programmed double-strand breaks that must be precisely repaired; defects in this machinery can allow autoreactive B-cell clones to escape negative selection. RAD51 expression is markedly elevated in B cells undergoing class switch recombination in vivo, suggesting that the RAD51 paralog network — including RAD51B — plays a direct role in maintaining immune tolerance during antibody diversification.

The rs911263 variant itself lies within an intron of RAD51B and does not change the protein sequence. It functions as a proxy SNP, tagging a larger haplotype block that likely influences RAD51B expression level, splicing efficiency, or regulatory element activity in immune cells. The functional variant has not been resolved at single-nucleotide resolution, but the locus-level association with anti-CCP-positive RA is replicated and genome-wide significant.

The Evidence

McAllister et al. (2013)³³ McAllister et al. (2013)
Meta-analysis in Arthritis & Rheumatism; combined ImmunoChip discovery data with two independent validation cohorts for 17,581 RA cases and 20,160 controls; anti-CCP subgroup analysis to identify serotype-specific loci identified rs911263 as a genome-wide significant RA susceptibility locus specifically in the seropositive (anti-CCP-positive) RA subgroup (p = 4 × 10⁻⁸, OR 0.89 per C allele). The effect was consistent across discovery and validation cohorts, and all SNPs at the locus showed ORs in the same direction. This study simultaneously identified BACH2 — a key B-cell transcription factor — at an adjacent locus, reinforcing the biological theme of B-cell regulation at this chromosomal region.

Luo et al. (2017)⁴⁴ Luo et al. (2017)
Two-stage case-control study in Han Chinese (965 RA cases, 2,511 controls); examined multiple RAD51B variants; assessed both disease susceptibility and radiographic erosion as outcomes replicated and extended these findings in a Chinese population. The C allele of rs911263 was associated with significantly reduced RA risk (OR 0.64, p = 4.8 × 10⁻⁵) and, strikingly, with reduced joint erosion severity among RA patients (OR 0.52, p = 2.89 × 10⁻⁵). The erosion finding — an independent association with disease progression rather than just onset — is notable because it suggests this locus may influence the auto-inflammatory cascade that destroys cartilage and bone after RA is established, not only the initial loss of tolerance.

The evidence level is moderate: the association is replicated across European and Asian cohorts, the p-value achieves genome-wide significance in the largest meta-analysis, and the biological mechanism (DNA repair in immune cells) is plausible. However, the causal variant within the RAD51B locus has not been functionally resolved, and the effect size is modest (OR 0.89 in Europeans).

Practical Actions

For TT homozygotes (most common genotype in non-African populations), the RA risk elevation at this locus is meaningful in the context of a cumulative genetic risk assessment for seropositive RA, and monitoring for early RA symptoms is worthwhile. For CC homozygotes, the protective C-allele haplotype is associated with both lower RA risk and less severe joint damage if RA does develop.

Anti-CCP antibody testing is the most sensitive and specific early biomarker for seropositive RA and is relevant to genetic risk assessment at this locus. Individuals with the TT genotype and a family history of RA, or other known RA risk factors, should discuss the clinical utility of anti-CCP screening with a rheumatologist.

Folate and dietary antioxidants have been studied in RA prevention and disease modification, partly because oxidative DNA damage can compromise HR repair fidelity. Ensuring adequate folate status (through diet and, for those with MTHFR variants, methylfolate supplementation) supports the homologous recombination machinery that RAD51B participates in.

Interactions

RAD51B acts together with RAD51C, RAD51D, and XRCC2 in the BCDX2 complex. Variants in RAD51C (rs28363317) and XRCC2 (rs3218536) could compound with rs911263 to further impair homologous recombination in immune cells, though no published study has directly examined the combination in the context of RA risk.

The proximity of rs911263 to the BACH2 locus (the adjacent RA susceptibility signal identified by McAllister et al.) is of biological interest: BACH2 is a master regulator of B-cell development and tolerance, and variants at both loci affecting anti-CCP-positive RA risk may act through the same B-cell differentiation programme.